UnitedHealth Group (NYSE:UNH) Shares Acquired Rep. Tim Moore

Key Points

• Representative Tim Moore of North Carolina disclosed the purchase of UnitedHealth Group shares, investing between $15,001 and $50,000 on July 16th.
• UnitedHealth Group's stock recently faced a decline in earnings, reporting $4.08 EPS, which fell short of analysts' expectations of $4.45, alongside a revenue of $111.62 billion.
• The company has increased its quarterly dividend to $2.21 per share, reflecting a positive shift from its previous dividend of $2.10, with an annual yield of 3.6%.

Representative Tim Moore (R-North Carolina) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in UnitedHealth Group stock on July 16th.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $1.37 during midday trading on Thursday, hitting $244.42. 11,331,473 shares of the company were exchanged, compared to its average volume of 18,403,832. The firm's 50 day moving average price is $292.78 and its two-hundred day moving average price is $408.71. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $221.72 billion, a P/E ratio of 10.59, a PEG ratio of 1.59 and a beta of 0.43. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business posted $6.80 earnings per share. The business's revenue for the quarter was up 12.9% on a year-over-year basis. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.6%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 38.30%.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently modified their holdings of UNH. Financial Management Professionals Inc. lifted its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after acquiring an additional 17 shares during the period. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after buying an additional 20 shares during the period. Kolinsky Wealth Management LLC boosted its position in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after acquiring an additional 21 shares during the last quarter. Retirement Planning Group LLC raised its position in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after acquiring an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group grew its stake in UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after purchasing an additional 21 shares during the period. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Finally, Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $366.52.

Insider Activity

In other news, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.